USE OF KALLIKREIN I OR DERIVATIVE THEREOF IN TREATMENT OF VCI, PSCI OR CSVD

Title:

USE OF KALLIKREIN I OR DERIVATIVE THEREOF IN TREATMENT OF VCI, PSCI OR CSVD

Document Type and Number:

WIPO Patent Application WO/2023/142889

Kind Code:

A1

Abstract:

The present invention relates to a use of kallikrein I or a derivative thereof in the treatment of vascular cognitive impairment (VCI), post-stroke cognitive impairment (PSCI) or cerebral small vessel disease (CSVD).

More Like This:

WO/1993/010779	METHODS AND COMPOSITIONS FOR TREATING HYPERTENSION, ANGINA AND OTHER DISORDERS USING OPTICALLY PURE (-) AMLODIPINE
JP4402747	Substituted thiophenylalkenylcarboxylic acid guanidides and methods for their production
WO/2001/042368	SUBSTITUTED PHTHALOCYANINES AND THEIR PRECURSORS

Inventors:

MA BRUCE YONG (CN)
JIANG CHENYANG (CN)
WANG JUN (CN)
WANG HE (CN)
XU ZHEN (CN)

Application Number:

PCT/CN2022/144054

Publication Date:

August 03, 2023

Filing Date:

December 30, 2022

Export Citation:

Click for automatic bibliography generation Help

Assignee:

ZONHONBIOPHARMA INST INC (CN)

International Classes:

A61P9/08; A61K38/48; A61P9/10; A61P25/28

Foreign References:

CN104073482A	2014-10-01
CN107760661A	2018-03-06
CN101801406A	2010-08-11
CN101134105A	2008-03-05
CN101530611A	2009-09-16
CN110446501A	2019-11-12

Other References:

WANG, FENGSHAN ET AL.: "Physiological, Pharmacological Effects and Clinical Applications of Kallikrein", BIOCHEMICAL RESEARCH, 31 December 1997 (1997-12-31), pages 522 - 527, XP009548373

Download PDF:

View/Download PDF PDF Help

Previous Patent: METHOD FOR SYNTHESIZING HIGH-PURITY PLANT-DERIVED CHOLESTEROL

Next Patent: SYNTHESIS METHOD FOR HIGH-PURITY CHOLESTEROL